DRUG-seq Provides Unbiased Biological Activity Readouts for Neuroscience Drug DiscoveryJingyao Li, Robert J. Ihry, Steffen Renner et al.|ACS Chemical Biology|2022Cited by 34
In-Depth Characterization and Validation in <i>BRG1</i> -Mutant Lung Cancers Define Novel Catalytic Inhibitors of SWI/SNF Chromatin RemodelingZainab Jagani, Margaret E. McLaughlin, Gregg Chenail et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 9
DRUG-seq Provides Unbiased Biological Activity Readouts for Drug DiscoveryJingyao Li, Robert J. Ihry, Daniel Ho et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 1